Transcription of Externalities, public goods, and infectious diseases
{{id}} {{{paragraph}}}
Example: confidence
Externalities, public goods, and infectious diseases
Real-world economics review, issue no. 99 subscribe for free 25 Externalities, public goods, and infectious diseases Spencer Graves [Founder, , Kansas City, Missouri USA] Douglas Samuelson [President and Chief Scientist, InfoLogix, Inc., Annandale, Virginia USA] Copyright: Spencer Graves and Douglas Samuelson, 2022 You may post comments on this paper at Abstract COVID-19 has been mutating so fast that existing political and economic systems may not be able to control it without (a) getting many more people vaccinated and complying with other public health measures like masks, and (b) more effective vaccines than currently available. This article discusses externalities and other economic phenomena associated with managing infectious diseases . The history of COVID-19 suggests that a better understanding of these issues might help economists make better contributions to improving the effectiveness of public health measures for this and other infectious diseases .
2 See the discussion of vaccine hesitancy below, esp. incl. "liability insurance for contagious diseases". ... that means that we will need 87.5 percent (= 1-1/8) of humanity immune or otherwise protected from exposure to this disease to stop the number of new cases from
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: